BRONZUOLI, MARIA ROSANNA
 Distribuzione geografica
Continente #
NA - Nord America 897
EU - Europa 330
AS - Asia 136
AF - Africa 27
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 1.401
Nazione #
US - Stati Uniti d'America 883
IT - Italia 249
IN - India 63
CN - Cina 60
SE - Svezia 27
TG - Togo 25
UA - Ucraina 17
CA - Canada 14
FR - Francia 9
AR - Argentina 8
FI - Finlandia 7
SG - Singapore 7
IE - Irlanda 5
BG - Bulgaria 3
DE - Germania 3
JP - Giappone 3
RO - Romania 3
XK - ???statistics.table.value.countryCode.XK??? 3
CH - Svizzera 2
IR - Iran 2
NL - Olanda 2
PL - Polonia 2
GB - Regno Unito 1
NG - Nigeria 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 1.401
Città #
Rome 157
Fairfield 123
Chandler 95
Ashburn 79
Wilmington 55
Seattle 50
Woodbridge 50
Houston 48
Beijing 42
Cambridge 42
Princeton 36
Plano 29
Lomé 25
Millbury 19
San Paolo di Civitate 19
Boston 16
Dearborn 16
Andover 11
Ann Arbor 11
Lawrence 11
Norwalk 11
San Diego 10
Federal 8
Surat 8
San Mateo 7
Cagliari 6
Buffalo 5
Dublin 5
Milan 5
Singapore 5
Toronto 5
La Spezia 4
Ottawa 4
Paradise 4
Pescara 4
Phoenix 4
Saint-cyprien 4
Bussi sul Tirino 3
New York 3
Pristina 3
Rochester 3
Shenyang 3
Sofia 3
Adachi 2
Bologna 2
Casnate Con Bernate 2
Castrovillari 2
Falls Church 2
Hefei 2
Indiana 2
Jacksonville 2
Las Vegas 2
Mulazzano 2
Nanjing 2
Nuvolera 2
Portici 2
Tehran 2
Tolentino 2
Washington 2
Aversa 1
Baotou 1
Bern 1
Chengdu 1
Cracow 1
Cuneo 1
Des Moines 1
Guangzhou 1
Guiyang 1
Hanoi 1
Irvine 1
Latina 1
Laurel 1
Lexington 1
Los Angeles 1
Mcallen 1
Montréal 1
Muizenberg 1
Palo Del Colle 1
Quzhou 1
Redmond 1
Redwood City 1
Sacramento 1
Salerno 1
San Gennaro 1
Taiyuan 1
Wenzhou 1
Totale 1.110
Nome #
Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects 105
Astrocyte Function Is Affected by Aging and Not Alzheimer’s Disease: A Preliminary Investigation in Hippocampi of 3xTg-AD Mice 99
Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease 95
Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer’s disease 83
The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin system 81
Altered brain cholesterol/isoprenoid metabolism in a rat model of autism spectrum disorders 78
Astrocyte: an innovative approach for Alzheimer's disease therapy 76
Palmitoylethanolamide dampens reactive astrogliosis and improves neuronal trophic support in a triple transgenic model of Alzheimer’s disease: in vitro and in vivo evidence 75
Neuroglia in the autistic brain: evidence from a preclinical model 73
Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes 72
An animal model of Alzheimer disease based on the intrahippocampal injection of amyloid beta-peptide (Abeta) 50
Glia-neuron interplay in health and disease: pharmacological evidence for this required teamwork 49
Sirtuin modulators control reactive gliosis in an in vitro model of alzheimer's disease 47
Preparation of rat hippocampal organotypic cultures and application to study amyloid beta-peptide toxicity 38
Targeting neuroinflammation in Alzheimer’s disease 36
Ultramicronized palmitoylethanolamide improves learning and memory in a triple transgenic mouse model of Alzheimer's disease through a combination of anti-inflammatory and neuroprotective effects 36
null 35
The protective effects of ultramicronized palmitoylethanolamide on the glutamatergic system in a triple transgene mouse model of Alzheimer disease. 34
Astrocyte-neuron interplay in Alzheimer's disease: evidence from an innovative and promising pharmacological manipulation in a triple transgenic model of the disease 33
Reactive astrogliosis and neuronal impairment: in vitro and in vivo evidence on palmitoylethanolamide effects in a triple transgenic model of Alzheimer’s disease 32
Investigating the role of oligodendrocytes in a pharmacological model of autism spectrum disorders 27
Sirtuins blunt reactive gliosis in an in vitro model of Alzheimer’s disease. 25
Astrocytes and Alzheimer’s disease: the pharmacological manipulation as promising tool against pathology progression. Evidence from a triple transgenic model of the disease 25
Effect of ultramicronized-palmytoilethanolamide on astrocyte dysfunction in a triple transgenic model of Alzheimer’s disease 25
Neuroprotective effects of palmitoylethanolamide in Alzheimer’s disease 24
Palmitoylethanolamide exerts neuroprotective effects in an in vivo model of Alzheimer’s disease 24
Effect of palmytoilethanolamide in 3xTg-AD astrocytes as in vitro model of Alzheimer’s disease 24
Looking for a treatment for the early stage of Alzheimer’s disease: preclinical evidence with co-ultramicronized palmitoylethanolamide and luteolin 22
Effect of palmitoylethanolamide in a triple transgenic model of Alzheimer’s disease 21
Palmitoylethanolamide controls astrocyte activation and the amyloidogenic pathway in an in vivo model of Alzheimer’s disease 18
Effect of palmitoylethanolamide on astrocyte activity in a triple transgenic model of Alzheimer’s disease 17
null 16
Is the modulation of reactive astrocytes a promising strategy for AD therapy? Preclinical experience with palmitoylethanolamide 6
Totale 1.501
Categoria #
all - tutte 3.904
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.904


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019121 0 0 0 0 0 0 0 0 0 0 56 65
2019/2020326 53 6 21 15 26 38 43 28 29 37 21 9
2020/2021142 14 7 3 10 5 2 0 6 13 44 20 18
2021/2022291 4 17 34 3 41 13 3 28 28 17 36 67
2022/2023310 67 78 13 15 40 24 0 18 40 4 5 6
2023/2024142 12 30 8 17 13 16 15 13 0 14 4 0
Totale 1.501